ID

14286

Descripción

Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101); ODM derived from: https://clinicaltrials.gov/show/NCT00306163

Link

https://clinicaltrials.gov/show/NCT00306163

Palabras clave

Versiones (1)
  1. 7/4/16 7/4/16 -
Titular de derechos de autor

CC BY-NC 3.0

Subido en

7 de abril de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Asthma NCT00306163

Inglés

Eligibility Asthma NCT00306163

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00306163
Criteria
Descripción

Criteria

history of bronchial asthma
Descripción

history of bronchial asthma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004096
fev1 > 1.20 l
Descripción

fev1

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0748133
positive skin prick test
Descripción

positive skin prick test

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0430561
not more than 500 mcg/day fluticasone propionate or equivalent for at least 28 days prior to baseline visit
Descripción

fluticasone propionate

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0117996
UMLS CUI [1,2]
C0040223
main exclusion criteria:
Descripción

exclusion criteria

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
clinically relevant abnormal laboratory values
Descripción

clinically relevant abnormal laboratory values

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1254595
UMLS CUI [1,2]
C2826293
concomitant severe diseases, diseases expected to interfere with the outcome of the study and diseases which are contra-indications for the use of inhaled steroids
Descripción

concomitant severe diseases, diseases expected to interfere with the outcome of the study and diseases which are contra-indications for the use of inhaled steroids

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
UMLS CUI [2,1]
C0586793
UMLS CUI [2,2]
C0439801
UMLS CUI [2,3]
C0009488
chronic obstructive pulmonary disease (copd) and /or other relevant lung diseases
Descripción

copd or other relevant lung diseases

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0024117
UMLS CUI [1,2]
C0024115
one asthma exacerbation within 2 months or more than 3 exacerbations within the last year prior to baseline visit
Descripción

asthma exacerbation

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0349790
UMLS CUI [1,2]
C0040223
current smokers or ex-smokers with more than 10 pack years, or having smoked within 1 year prior to baseline visit
Descripción

smoking history

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1519384
UMLS CUI [2]
C1277691
positive response to saline challenge at baseline visits
Descripción

saline challenge

Tipo de datos

boolean

positive bronchial hyperresponsiveness
Descripción

bronchial hyperresponsiveness

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0085129
Volver a la parte superior de la página

Similar models

Eligibility Asthma NCT00306163

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00306163
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
history of bronchial asthma
Item
history of bronchial asthma
boolean
C0004096 (UMLS CUI [1])
fev1
Item
fev1 > 1.20 l
boolean
C0748133 (UMLS CUI [1])
positive skin prick test
Item
positive skin prick test
boolean
C0430561 (UMLS CUI [1])
fluticasone propionate
Item
not more than 500 mcg/day fluticasone propionate or equivalent for at least 28 days prior to baseline visit
boolean
C0117996 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
exclusion criteria
Item
main exclusion criteria:
boolean
C0680251 (UMLS CUI [1])
clinically relevant abnormal laboratory values
Item
clinically relevant abnormal laboratory values
boolean
C1254595 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
concomitant severe diseases, diseases expected to interfere with the outcome of the study and diseases which are contra-indications for the use of inhaled steroids
Item
concomitant severe diseases, diseases expected to interfere with the outcome of the study and diseases which are contra-indications for the use of inhaled steroids
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0586793 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C0009488 (UMLS CUI [2,3])
copd or other relevant lung diseases
Item
chronic obstructive pulmonary disease (copd) and /or other relevant lung diseases
boolean
C0024117 (UMLS CUI [1,1])
C0024115 (UMLS CUI [1,2])
asthma exacerbation
Item
one asthma exacerbation within 2 months or more than 3 exacerbations within the last year prior to baseline visit
boolean
C0349790 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
smoking history
Item
current smokers or ex-smokers with more than 10 pack years, or having smoked within 1 year prior to baseline visit
boolean
C1519384 (UMLS CUI [1])
C1277691 (UMLS CUI [2])
saline challenge
Item
positive response to saline challenge at baseline visits
boolean
bronchial hyperresponsiveness
Item
positive bronchial hyperresponsiveness
boolean
C0085129 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial